Literature DB >> 2910471

Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue.

A Hennipman1, B A van Oirschot, J Smits, G Rijksen, G E Staal.   

Abstract

Tyrosine specific protein kinase activity was determined in 70 specimens of the human mammary gland. These included 28 cancers of the breast, 21 benign breast diseases, and 21 normal breast tissues. We measured tyrosine kinase activity in the cytosol fraction and in the membrane fraction of the homogenates. In addition cytosolic aldolase activity was measured. Tyrosine kinase activity was determined using poly(glutamic acid:tyrosine = 4:1) as an artificial substrate. Cancers of the breast exhibited considerable higher tyrosine kinase activities in both cytosol and membrane fractions, compared to benign breast tumors (P less than or equal to 0.001). Benign tumors demonstrated increased activities in cytosol in comparison to normal breast tissues (P less than 0.001). Furthermore, there appears to be a strong association of an enhanced expression of activity of tyrosine kinase in cytosol of primary carcinomas and early systemic relapse. In combination with aldolase activity a nearly complete discrimination is achieved between malignant specimens on one hand and benign and normal tissues on the other.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2910471

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary results.

Authors:  M Bolla; B Rostaing-Puissant; S P Bottari; M Chedin; J Marron-Charriere; M Colonna; E Berland; E Chambaz
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  An enzyme-linked immunosorbent assay for the determination of src-family tyrosine kinase activity in breast cancer.

Authors:  G Rijksen; S S Adriaansen-Slot; G E Staal
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 3.  SH2 domain-containing signaling proteins in human breast cancer.

Authors:  R J Daly
Journal:  Breast Cancer Res Treat       Date:  1995-04       Impact factor: 4.872

4.  Elevated insulin receptor content in human breast cancer.

Authors:  V Papa; V Pezzino; A Costantino; A Belfiore; D Giuffrida; L Frittitta; G B Vannelli; R Brand; I D Goldfine; R Vigneri
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  Protein tyrosine kinases in human breast cancer: kinetic properties and evidence for the presence of two forms of native enzyme.

Authors:  Y Durocher; S Chevalier
Journal:  Breast Cancer Res Treat       Date:  1990-12       Impact factor: 4.872

Review 6.  Protein kinases in human breast cancer.

Authors:  W G Cance; E T Liu
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

7.  Protein tyrosine (de-)phosphorylation in head and neck squamous cell carcinoma.

Authors:  H P Verschuur; G Rijksen; B A van Oirschot; G P Schipper-Kester; P J Slootweg; G E Staal; G J Hordijk
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

8.  Enzymatic and immunohistochemical evaluation of tyrosine phosphorylation in breast cancer specimens.

Authors:  E E Lower; R S Franco; M A Miller; O J Martelo
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

9.  Protein tyrosine kinase activity as a prognostic parameter in breast cancer, a pilot study.

Authors:  M Bolla; B R Rostaing-Puissant; M Chedin; C Souvignet; J Marron-Charriere; M Colonna; E Berland; E M Chambaz
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Increased phosphotyrosine in breast cancer tissue is associated with a worse prognosis.

Authors:  E E Lower; M A Miller; L Williams; C Westermann; S Heffelfinger
Journal:  Breast Cancer Res Treat       Date:  1995-09       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.